Martin Leon
Interventional Cardiology · New York, NYNPI 1669559480
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (52.2%), other and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Corindus Inc. at 43.7% of the total. Reporting peaked in 2019 at $810,310 and has fallen 95.1% since, to $39,465 in 2025. Among interventional cardiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $4138.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corindus Inc.$658K
- Edwards Lifesciences$504K
- Boston Scientific$156K
- Johnson & Johnson$139K
- W. L. Gore & Associates, Inc.$13K
- Medtronic$11K
- plus $25K from 9 others
Across 28 payments — averaging $429,980 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$11.9M
- Medtronic$109K
What the payments were for
- Consulting fees$79,3965%
- Speaking & faculty fees$15,0251%
- Grants$7,5220%
- Travel & lodging$57,6704%
- Food & beverage$20,0801%
- Entertainment$6750%
- Ownership interest$786,70052%
- Other$539,23236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corindus Inc. | 1 | $657,800 |
| Edwards Lifesciences | 200 | $503,608 |
| Boston Scientific | 50 | $156,324 |
| Johnson & Johnson | 1 | $139,232 |
| W. L. Gore & Associates, Inc. | 9 | $13,322 |
| Medtronic(2 entities) | 40 | $11,233 |
| Ancora Heart, Inc. | 30 | $10,068 |
| Cordis US CORP. | 5 | $7,527 |
| Abbott | 14 | $2,587 |
| Opsens Inc. | 3 | $1,783 |
| Croivalve Inc | 2 | $1,549 |
| Abiomed | 6 | $954 |
| Cathworks, Inc. | 1 | $188 |
| Endotronix, Inc. | 1 | $108 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$132,976
- Edwards SAPIEN 3 Transcatheter Heart Valve$25,940
- Product in Development$13,253
- AccuCinch$8,338
- GENERAL - STRUCTURAL HEART$7,002
- SELUTION SLR PTA$6,500
- GENERAL VASCULAR ACCESS$5,200
- Watchman$2,500
- SavvyWire$1,500
- Resolute$1,125
- SAPIEN 3 Ultra RESILIA$921
- cardio$805
- Impella$772
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$751
- LINGO$642
- MitraClip$544
- APOLLOTM$377
- Edwards SAPIEN XT Transcatheter Heart Valve$370
- CoreValve Evolut$332
- ACCOLADE SR$299
How this compares
$1,506,299 in reported general payments places this provider in the 95th percentile of 382 interventional cardiology providers in New York.
Other interventional cardiology in New York
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- Prakash KrishnanNew York$387K
- Jaikirshan KhatriNew York$307K
- Samin SharmaNew York$291K
- Torsten VahlNew York$280K
- George DangasNew York$263K
- Jeffrey MosesNew York$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.